IP Library Granted Patent US 11,096,602
Granted Patent B2
US 11,096,602 · App. 15/663,290 · Granted Aug 24, 2021

Methods and systems for characterizing tissue of a subject utilizing a machine learning

Inventors: Lina Gurevich (Vancouver, CA); Lori Ann Swalm (Dallas, TX)
Assignee: Stryker European Operations Limited
A61B5/0275A61B5/0261A61B5/7232A61B5/7267A61B5/743G06K9/6218G06K9/6219G06K9/6223G06K9/6274G06K9/66G06T7/0012G06T7/557A61B2576/00G06K2209/05G06T2207/10024G06T2207/10064G06T2207/10081G06T2207/10104G06T2207/30024G06T2207/30104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,096,602
App. No.
15/663,290
Granted
Aug 24, 2021
Kind
B2
Abstract

Methods and systems for characterizing tissue of a subject include acquiring and receiving data for a plurality of time series of fluorescence images, identifying one or more attributes of the data relevant to a clinical characterization of the tissue, and categorizing the data into clusters based on the attributes such that the data in the same cluster are more similar to each other than the data in different clusters, wherein the clusters characterize the tissue. The methods and systems further include receiving data for a subject time series of fluorescence images, associating a respective cluster with each of a plurality of subregions in the subject time series of fluorescence images, and generating a subject spatial map based on the clusters for the plurality of subregions in the subject time series of fluorescence images. The generated spatial maps may then be used as input for tissue diagnostics using supervised machine learning.

Claims (58)

1. A method for characterizing tissue of a subject, the method comprising,

at a computer system having one or more processors and a display:

receiving data for a time series of fluorescence images of the tissue of the subject, the time series of fluorescence images being or having been captured by an image capture system;

identifying one or more attributes of the data that are relevant to a clinical characterization of the tissue;

determining a number of clusters for categorization of the data into a plurality of clusters, wherein determining the number of clusters comprises comparing performance of a plurality of clusterings, wherein comparing performance of the plurality of clusterings comprises assessing respective distortions for the plurality of clusterings;

categorizing the data into the determined number of clusters based on the one or more attributes of the data such that data in the same cluster are more similar to each other than the data are to data in other clusters, wherein the clusters characterize the tissue;

generating a spatial map representing clinical characterization of the tissue, wherein the spatial map comprises a plurality of spatial values associated with spatial regions of the tissue and each spatial value is generated based on a cluster of the plurality of clusters; and

displaying an image based on the spatial map.

2. The method of claim 1 , wherein the data for the plurality of time series of fluorescence images of the subject comprises raw data, pre-processed data, or a combination thereof.

3. The method of claim 2 , wherein the pre-processed data is pre-processed by applying data compression, principal component analysis, autoencoding, or a combination thereof.

4. The method of claim 1 , wherein the one or more attributes of the data relevant to the clinical characterization of the tissue are identified for a plurality of subregions in the time series of fluorescence images of the subject.

5. The method of claim 4 , wherein at least one of the subregions is a pixel or a voxel in the time series of fluorescence images.

6. The method of claim 4 , wherein at least one of the subregions is a group of pixels or a group of voxels in the time series of fluorescence images of the subject.

7. The method of claim 1 , wherein the one or more attributes of the data for the time series of fluorescence images of the subject comprise a time-intensity curve, a coefficient, spatial position, onset time, time to blush, maximum fluorescence intensity, ingress of blood, egress of blood, or a combination thereof.

8. The method of claim 1 , wherein the clusters characterize the tissue based on spatial distribution of the clusters, properties of the clusters, cluster data, or a combination thereof.

9. The method of claim 8 , wherein properties of the clusters comprise shape of the clusters.

10. The method of claim 1 , wherein each cluster is represented by a centroid.

11. The method of claim 10 , wherein a centroid of a cluster is indicative of which of the one or more attributes of the data for the time series of fluorescence images of the subject contributes to data categorization.

12. The method of claim 1 , wherein categorizing the data for the time series of fluorescence images of the subject into the plurality of clusters comprises categorizing the data into ten or fewer clusters.

13. The method of claim 1 , wherein categorizing the data for the time series of fluorescence images of the subject comprises applying an unsupervised clustering algorithm.

14. The method of claim 13 , wherein the clustering algorithm is a K-means algorithm.

15. The method of claim 1 , wherein the spatial map represents differences in blood flow, perfusion patterns, or a combination thereof among the spatial regions of the tissue.

16. The method of claim 1 , further comprising training a machine learning model based on the categorized data.

17. The method of claim 16 , wherein the machine learning model is trained in a supervised machine learning algorithm.

18. The method of claim 1 , further comprising:

receiving data for a subject time series of fluorescence images of the tissue of the subject;

associating a respective cluster of the plurality of clusters with each of a plurality of subregions in the subject time series of fluorescence images;

generating a subject spatial map based on the associated clusters for the plurality of subregions in the subject time series of fluorescence images; and

displaying the subject spatial map.

19. The method of claim 18 , wherein generating the subject spatial map comprises assigning at least one of an intensity value and a color to each subregion in the subject time series of fluorescence images based on the associated cluster.

20. The method of claim 1 , wherein comparing performance of the plurality of clusterings comprises calculating a cumulative distortion for the plurality of clusterings.

21. A system comprising:

a display;

one or more processors;

memory; and

one or more programs, wherein the one or more programs are stored in the memory and configured to be executed by the one or more processors, the one or more programs including instructions for:

receiving data for a time series of fluorescence images of the tissue of the subject, the time series of fluorescence images being or having been captured by an image capture system;

identifying one or more attributes of the data that are relevant to a clinical characterization of the tissue;

determining a number of clusters for categorization of the data into a plurality of clusters, wherein determining the number of clusters comprises comparing performance of a plurality of clusterings, wherein comparing performance of the plurality of clusterings comprises assessing respective distortions for the plurality of clusterings;

categorizing the data into the determined number of clusters based on the one or more attributes of the data such that data in the same cluster are more similar to each other than the data are to data in other clusters, wherein the clusters characterize the tissue;

generating a spatial map representing clinical characterization of the tissue, wherein the spatial map comprises a plurality of spatial values associated with spatial regions of the tissue and each spatial value is generated based on a cluster of the plurality of clusters; and

displaying an image based on the spatial map.

22. The system of claim 21 , wherein the one or more programs include instructions for superimposing the image on an anatomical image of the tissue.

23. The system of claim 21 , further comprising a light source that provides an excitation light to induce fluorescence emission from a fluorescence imaging agent in the tissue.

24. The system of claim 23 , further comprising an image acquisition assembly configured to generate the time series of fluorescence images based on the fluorescence emission.

25. A non-transitory computer-readable storage medium storing one or more programs for execution by a computing system with one or more processors and a display, the one or more programs comprising instructions for:

receiving data for a time series of fluorescence images of the tissue of the subject, the time series of fluorescence images being or having been captured by an image capture system;

identifying one or more attributes of the data that are relevant to a clinical characterization of the tissue;

determining a number of clusters for categorization of the data into a plurality of clusters, wherein determining the number of clusters comprises comparing performance of a plurality of clusterings, wherein comparing performance of the plurality of clusterings comprises assessing respective distortions for the plurality of clusterings;

categorizing the data into the determined number of clusters based on the one or more attributes of the data such that data in the same cluster are more similar to each other than the data are to data in other clusters, wherein the clusters characterize the tissue;

generating a spatial map representing clinical characterization of the tissue, wherein the spatial map comprises a plurality of spatial values associated with spatial regions of the tissue and each spatial value is generated based on a cluster of the plurality of clusters; and

displaying an image based on the spatial map.

26. A method for characterizing tissue of a subject, the method comprising:

receiving data for a subject time series of fluorescence images of the subject, the subject time series of fluorescence images of the subject being or having been acquired by an image acquisition device;

determining a number of subregions for association of the data with a plurality of subregions, wherein determining the number of subregions comprises comparing performance of a plurality of clusterings, wherein comparing performance of the plurality of clusterings comprises assessing respective distortions for the plurality of clusterings;

associating a respective category of a predetermined plurality of categories with each of the determined number of subregions in the subject time series of fluorescence images, wherein the categories characterize tissue and are based on one or more attributes relevant to a clinical characterization of tissue, such that a subregion associated with a given category is more similar to other subregions associated with the given category than subregions associated with other categories;

generating a spatial map representing the tissue based on the associated categories for the plurality of subregions in the subject time series of fluorescence images; and

displaying the spatial map as an image.

Assignments (16)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2019
From: GUREVICH, LINA; SWALM, LORI ANN
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 049032/0909 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →
Continuity (3)
Provisional Application 62368960 · Jul 29, 2016
Provisional Application 62368971 · Jul 29, 2016
Related Publication 20180028079A1 · Feb 1, 2018